BioRestorative Therapies, Inc.
BRTX
$1.71
$0.021.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.81% | -34.20% | 77.20% | 64.90% | 21.21% |
| Total Depreciation and Amortization | 14.12% | 17.18% | 21.75% | 26.21% | 37.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.93% | 266.84% | -134.27% | -113.41% | -53.91% |
| Change in Net Operating Assets | -94.43% | 36.22% | 134.12% | 212.54% | 3,554.61% |
| Cash from Operations | -27.99% | -15.68% | -3.27% | 4.91% | -8.75% |
| Capital Expenditure | 37.86% | -14.15% | -9.53% | 48.59% | 35.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.87% | -496.58% | 79.94% | 61.05% | 126.06% |
| Cash from Investing | -84.18% | -1,284.53% | 78.96% | 60.79% | 124.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 245.85% | 262.21% | 2,199.03% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 214.18% | 234.94% | 2,193.61% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.43% | 75.98% | 102.68% | 95.89% | 95.71% |